Myeong Yim - Daihan Pharmaceutical Internal Auditor

023910 Stock  KRW 27,250  600.00  2.25%   

Executive

Yim Myeong Heok is Internal Auditor of DaehanPharmaceutical. Prior to that Yim worked for Dongah Construction Industrial Co. Ltd. Yim holds a Bachelor degree in Commerce from Sungkyunkwan University Korea.
Age 67
Phone82 2 2678 3911
Webhttps://www.daihan.com

Daihan Pharmaceutical Management Efficiency

The company has return on total asset (ROA) of 0.0677 % which means that it generated a profit of $0.0677 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 12.4908 %, meaning that it generated $12.4908 on every $100 dollars invested by stockholders. Daihan Pharmaceutical's management efficiency ratios could be used to measure how well Daihan Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.
Daihan Pharmaceutical CoLtd has accumulated 14 B in total debt with debt to equity ratio (D/E) of 0.15, which may suggest the company is not taking enough advantage from borrowing. Daihan Pharmaceutical has a current ratio of 3.06, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Daihan Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Daihan Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Daihan Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Daihan to invest in growth at high rates of return. When we think about Daihan Pharmaceutical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

EXECUTIVE Age

Kwang LeeKorean Air Lines
N/A
Tai SukKorean Air Lines
N/A
Kyung ChoiKorean Air Lines
N/A
Doo ParkNational Plastic Co
75
NamIl ParkKorean Air Lines
70
TaeKeun HanAir Busan Co
N/A
KyungHwan ChangKorean Air Lines
73
,Ltd. manufactures and sells various medicinal products in South Korea. ,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. DaihanPharm is traded on Korean Securities Dealers Automated Quotations in South Korea. Daihan Pharmaceutical CoLtd (023910) is traded on KOSDAQ in Korea and employs 7 people.

Management Performance

Daihan Pharmaceutical Leadership Team

Elected by the shareholders, the Daihan Pharmaceutical's board of directors comprises two types of representatives: Daihan Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Daihan. The board's role is to monitor Daihan Pharmaceutical's management team and ensure that shareholders' interests are well served. Daihan Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Daihan Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yun Lee, Chief Executive Officer, Director
Dong Lee, President Director
YoonWoo Lee, Chairman Officer
Myeong Yim, Internal Auditor
Mun Lee, Non-Executive Independent Director
Bok Yum, Director

Daihan Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Daihan Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Daihan Pharmaceutical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Daihan Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daihan Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Daihan Stock

  0.72047920 HLB PharmaceuticalPairCorr

Moving against Daihan Stock

  0.36106190 High Tech PharmPairCorr
The ability to find closely correlated positions to Daihan Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Daihan Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Daihan Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Daihan Pharmaceutical CoLtd to buy it.
The correlation of Daihan Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Daihan Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Daihan Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Daihan Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Daihan Stock

Daihan Pharmaceutical financial ratios help investors to determine whether Daihan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Daihan with respect to the benefits of owning Daihan Pharmaceutical security.